Xtant Medical Holdings Inc (XTNT) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Xtant Medical Holdings Inc   (NYSEAMER: XTNT)
 

Xtant Medical Holdings Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Xtant Medical Holdings Inc inventory turnover ratio, the Xtant Medical Holdings Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 1.28 in the second quarter 2026, XTNT's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Xtant Medical Holdings Inc in Jun 30 2026 quarter, has decreased to 285 days, compare to 290 days, in the Mar 31 2026 quarter.

Within Healthcare sector 285 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 1772, from total ranking in the first quarter 2026 at 1911.

XTNT Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Xtant Medical Holdings Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

XTNT Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth -17.06 % -17.86 % -21.67 % -2.8 % -0.92 %
Y / Y Cost of Sales Growth -11.81 % -33.33 % -11.76 % 0 % 0 %
Inventory Turnover Ratio (TTM) 1.28 1.26 1.31 1.29 1.28
XTNT's Total Ranking # 1772 # 1911 # 1836 # 1838 # 1845
Average inventory processing period 284 290 279 283 285
Seq. Inventory Growth 4.41 % 5.35 % -25.67 % 1.44 % 3.41 %
Seq. Cost of Sales Growth 21.26 % -46.67 % 36.36 % 0 % -8.33 %




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 19
Healthcare Sector # 286
Overall Market # 1772

Inventory Turnover Ratio Statistics
High Average Low
1.62 1.19 0.57
(Sep 30 2019)   (Jun 30 2012)



XTNT Company Profile >> Back to XTNT Efficiency Comparisons >> Compare XTNT Inventory Turnover Ratio to its Competitors

Financial Statements
Xtant Medical Holdings Inc 's Inventories $ 33 Millions Visit XTNT's Balance sheet
Xtant Medical Holdings Inc 's Cost of Revenues TTM $ 44 Millions Visit XTNT's Income Statement
What are XTNT's Sales? Visit XTNT's Sales by Segment

Other Inventory Turnover Ratios
Xtant Medical Holdings Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
XTNT's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for XTNT's Competitors
Inventory Turnover Ratio for XTNT's Suppliers
Inventory Turnover Ratio for XTNT's Customers

You may also want to know
XTNT's Sales Growth Rates XTNT's Pe Price to earnings ratio XTNT's Receivables Turnover Ratio XTNT's Stock Quote
XTNT's Net Income Growth Rates XTNT's Ps Price to Sales ratio XTNT's Sales per Employee XTNT's Asset Turnover Ratio
XTNT's Net Margin XTNT's Pb Price to Book ratio XTNT's Financial Strength Ratios XTNT's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Neuraxis Inc   3.55 $ 0.783  Millions$ 0  Millions
Beyond Air Inc   3.51 $ 6.447  Millions$ 2  Millions
Nexgel Inc   3.49 $ 7.577  Millions$ 2  Millions
Lifeward ltd   3.47 $ 13.976  Millions$ 4  Millions
Bellevue Life Sciences Acquisition Corp  3.38 $ 1.215  Millions$ 0  Millions
10x Genomics Inc   3.29 $ 184.539  Millions$ 56  Millions
Biofrontera Inc   3.28 $ 6.622  Millions$ 2  Millions
Maravai Lifesciences Holdings Inc   3.22 $ 135.038  Millions$ 42  Millions
Agilent Technologies inc   3.20 $ 3,404.000  Millions$ 1,064  Millions
Mettler toledo International Inc   3.18 $ 1,277.460  Millions$ 401  Millions
Bionexus Gene Lab Corp   3.15 $ 2.362  Millions$ 1  Millions
Eton Pharmaceuticals Inc   3.11 $ 44.176  Millions$ 14  Millions
Mimedx Group Inc   3.07 $ 75.981  Millions$ 25  Millions
Revvity Inc  2.98 $ 1,136.473  Millions$ 381  Millions
Amneal Pharmaceuticals Inc   2.98 $ 1,891.689  Millions$ 635  Millions
Resmed Inc   2.97 $ 2,770.562  Millions$ 933  Millions
Msa Safety Inc  2.92 $ 1,021.036  Millions$ 350  Millions
Ligand Pharmaceuticals Incorporated  2.91 $ 32.387  Millions$ 11  Millions
Logicmark Inc  2.83 $ 3.881  Millions$ 1  Millions
Merck and Co Inc   2.79 $ 17,996.000  Millions$ 6,447  Millions
Inspiremd Inc   2.78 $ 8.847  Millions$ 3  Millions
Ani Pharmaceuticals Inc  2.69 $ 387.398  Millions$ 144  Millions
International Stem Cell Corporation  2.61 $ 4.285  Millions$ 2  Millions
Biomerica Inc   2.59 $ 4.091  Millions$ 2  Millions
Evofem Biosciences Inc   2.58 $ 4.418  Millions$ 2  Millions
Nephros Inc   2.54 $ 8.991  Millions$ 4  Millions
Illumina Inc   2.52 $ 1,510.000  Millions$ 599  Millions
IMPACT BIOMEDICAL INC.  2.46 $ 0.414  Millions$ 0  Millions
Quidelortho Corp  2.45 $ 1,481.500  Millions$ 605  Millions
Pro dex Inc   2.43 $ 53.213  Millions$ 22  Millions

Date modified: 2026-09-05T00:19:23+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.